finck

In its first part, this e-presentation explains how barriers to biosimilars can have an impact on access to affordable medicines and public health expenditure. In its second part, it explores the consequences of unjustly granted preliminary injunctions in patent litigation cases in the light of a recent ruling from the CJEU (C-688/17, Bayer vs Richter) and an interim decision adopted in the Netherland.

e-Presentation | March 2021 | Learning time: 41 minutes

Marleen van den Horst, Partner, BarentsKrans Coöperatief Advocaten, The Hague.

Watch the premium version     Purchase the premium version    

finck

This e-presentation looks at the EU legal framework for the promotion of pharmaceutical products (Directive 2001/83/EC) in the light of recent rulings adopted by the CJEU on online sales (C-649/18A) and on distribution of free samples (C-786/18) of pharmaceutical products. Issues related to advertising and over-the-counter products are also tackled.

e-Presentation | March 2021 | Learning time: 39 minutes

Dr Christian Tillmanns, Partner, Meisterernst Rechstanwälte, Munich.

Watch the premium version     Purchase the premium version    

vleeshouwers

This e-presentation presents flexible antitrust and State aid measures adopted by the European Commission in order to face the difficulties caused by Covid-19. It also looks at patent pooling, patent licensing and the EU's Covid-19 vaccine export controls.

e-Presentation | March 2021 | Learning time: 42 minutes

Domien Op de Beeck, Partner, Bird & Bird, Brussels and Baptist Vleeshouwers, Associate, Bird &Bird, Brussels.

Watch the premium version     Purchase the premium version    

speakere-Presentations

This e-presentation explains the regulatory specificities of biosimilars in the context of competition law and gives an overview of the expected strategies of the pharmaceutical industry to restrict competition of biosimilars on the market.

e-Presentation | March 2020 | Learning time: 34 minutes

Nicolas Pourbaix

Watch the premium version       Purchase the premium version    


speakere-Presentations

After giving a critical appraisal of the consequences of recent judgments adopted by the CJEU on access to documents held by EMA, this e-presentation presents some of the industry challenges raised by the implementation of the new in-vitro diagnostic regulation, as well as by Brexit.

e-Presentation | March 2020 | Learning time: 42 minutes

Elisabethann Wright

Watch the premium version       Purchase the premium version